Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose Using New Hepatitis B Bulk (Bio Farma), in Indonesian Infants

NCT05482282 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT05482282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05482282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose Using New Hepatitis B Bulk (Bio Farma), in Indonesian Infants
Lead sponsor
PT Bio Farma
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2025
Completion date
December 31, 2026
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria vaccine adverse reaction, haemophilus influenzae type b vaccine adverse reaction, hepatitis b vaccine adverse reaction, pertussis vaccine adverse reaction, tetanus vaccine adverse reaction